GoldenGolden
Onconova Therapeutics

Onconova Therapeutics

A company dveloping small molecule drugs for the treatment of cancer

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company that focuses on discovering and developing products for cancer patients. Its proprietary targeted anti-cancer agents are designed to disrupt specific cellular pathways that are important for cancer cell proliferation.

Onconova’s novel, proprietary multi-kinase inhibitor ON 123300 is planned to begin a dose-escalation and expansion Phase 1 trial in the U.S. in 2Q21, and a dose-escalation and expansion Phase 1 trial is currently underway in China. Its product candidate oral rigosertib, is currently in a dose-escalation and expansion Phase 1 investigator-initiated study, targeting patients with advanced KRAS+ lung adenocarcinoma in combination with nivolumab.

The company is dedictated to delivering novel solutions to cancer patients who are in need. It seeks to develop products that enhance the outcome for cancer patients by addressing the disease, its recurrence, and the burden of side-effects that are associated with the current methods of treatment.

Timeline

Funding rounds

People

Name
Role
LinkedIn

Gary Ugarek

Employee

Jagannath Samavedam

Investor

Rekha rout

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
FinancialNewsMedia.com
February 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- The incidence of cancer is increasing every year and it has been the major factor for the growth of the cancer vaccines market. Healthcare...
August 12, 2019
WebWire
Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on Myelodysplastic Syndromes (MDS), and Mission Bio, the pioneer in targeted single-cell DNA analysis and precision genomics, today announced that they have formed a collaboration to utilize the Mission Bio TapestriR Platform for targeted single-cell DNA analysis to study Onconova's novel cancer therapy, rigosertib, through...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.